Skip to main content
IXICO PLC logo

IXICO PLC — Investor Relations & Filings

Ticker · IXI ISIN · GB00BFXR4C20 LEI · 2138005M1F59O6HWSA97 IL Professional, scientific and technical activities
Open in API
Filings indexed 354 across all filing types
Latest filing 2023-03-21 Major Shareholding Noti…
Country GB United Kingdom
Listing IL IXI

About IXICO PLC

https://www.ixico.com/

IXICO PLC is a clinical research and data analytics company specializing in neuroscience. It provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials for neurological disorders. The company utilizes its proprietary, AI-driven technology platform to manage and analyze complex imaging and digital health data. This platform deploys disease-specific algorithms to generate reliable clinical data and precision insights, aiming to accelerate research and development decision-making, de-risk clinical studies, and support the advancement of new therapies for conditions such as Alzheimer's and Huntington's disease.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with "RNS Number : 7395T" and contains the standard header/footer information associated with RNS (Regulatory News Service) announcements from the London Stock Exchange. The content details a "TR-1: Standard form for notification of major holdings" due to an acquisition or disposal of voting rights by City Asset Management PLC, crossing a threshold. This type of mandatory disclosure regarding significant changes in share ownership falls directly under the definition of Major Shareholding Notification (MRQ). Although RNS is a general category, MRQ is more specific and accurate for this content.
2023-03-21 English
Contract Win
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 5037S' and concludes with information about RNS, the news service of the London Stock Exchange, stating 'This information is provided by RNS...'. The content announces a specific corporate event: a contract win for a clinical trial, including its value and nature. This is a typical announcement made via the Regulatory News Service (RNS). Since the document is short (under 5,000 characters) and serves as a direct announcement of a material event rather than a comprehensive report (like 10-K or IR), it fits best under the general regulatory announcement category, RNS, which serves as a fallback for specific corporate news releases distributed via the exchange's service.
2023-03-10 English
Trading Update
Earnings Release Classification · 1% confidence The document is identified by the 'RNS Number' header and contains a 'Trading update' from IXICO plc, dated 07 February 2023. It provides forward-looking statements regarding revenue expectations for FY2023 and FY2024, and includes contact information for the company and its broker. The footer explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a brief update disseminated via the RNS system—is characteristic of a general regulatory announcement that doesn't fit a more specific category like Earnings Release (ER) or Interim Report (IR). Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements. FY 2023
2023-02-07 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1909 characters) and contains an RNS Number (4715O) and mentions 'RNS, the news service of the London Stock Exchange' and the 'Financial Conduct Authority'. The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security's auction call period. This is a general regulatory announcement that does not fit the specific definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (DIV, DVA). Since it is a standard regulatory notification distributed via the RNS system and doesn't fit a more specific category, it defaults to the general Regulatory Filings category.
2023-01-31 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1926 characters) and its primary content is an announcement regarding a 'Second Price Monitoring Extension' for a security, referencing an RNS Number and providing contact information for RNS, the news service of the London Stock Exchange. This structure strongly indicates a general regulatory announcement or market notice rather than a detailed financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, CAP). Since it is a direct notification distributed via the RNS system and doesn't fit the specific categories like Director's Dealing (DIRS), Dividend (DIV), or Capital Change (CAP), the most appropriate classification is the general regulatory announcement fallback category.
2023-01-31 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document explicitly starts with 'RNS Number' and contains information about a 'Price Monitoring Extension' related to trading on the London Stock Exchange. It mentions that RNS is approved by the Financial Conduct Authority (FCA) to act as a Primary Information Provider. This structure and content strongly indicate a general regulatory announcement disseminated via the RNS system, rather than a specific financial report (like 10-K, IR, ER) or a specific corporate action (like DIV, DIRS, MANG). Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback category for a standard, short regulatory notice disseminated through the RNS service that doesn't fit a more specific category.
2023-01-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.